ServareGMP
banner
servaregmp.bsky.social
ServareGMP
@servaregmp.bsky.social
ServareGMP’s objective is to use its capabilities to meet the needs of the underserved, the neglected and the vulnerable
Last year, we were proud to have a strategic partnership with Bio Usawa to establish advanced monoclonal antibody manufacturing capabilities in Africa, helping address the critical healthcare access gap affecting patients in low- and middle-income countries.

www.globenewswire.com/news-release...
Bio Usawa Biotechnology and ServareGMP Form Strategic Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa
Strategic alliance brings advanced first-of-its-kind biotherapeutic production, workforce training, and rapid response capabilities to low- and...
www.globenewswire.com
February 13, 2026 at 8:09 PM
Our CEO, Gary Pierce, was recently featured in an article in @natbiotech.nature.com discussing the growing community of international non-profit organizations working to bring much needed life science innovations to underserved populations around the world!

www.nature.com/articles/s41...
Non-profits wade in where for-profit life science investment fears to tread - Nature Biotechnology
For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and ...
www.nature.com
February 10, 2026 at 7:12 PM
ServareGMP was established to help change this reality through three primary pathways:
February 6, 2026 at 6:56 PM
ServareGMP is a non-profit public benefit corporation dedicated to developing and manufacturing low-cost biologic medicines against infectious diseases, unmet needs and neglected diseases affecting the most vulnerable populations.
February 5, 2026 at 8:57 PM